
    
      Antiproteinuric Effects of Aliskiren (Renin Inhibitor), Irbesartan (Angiotensin Receptor
      Antagonist) and the Combination in Hypertensive Patients With Type 2 Diabetes and
      Incipient/Overt Diabetic Nephropathy
    
  